ENDOLOGIX INC's ticker is ELGX and the CUSIP is 29266S106.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $1,239,000 | -66.7% | 1,730,909 | -11.1% | 0.00% | – |
Q3 2018 | $3,721,000 | -71.0% | 1,948,114 | -14.0% | 0.00% | -100.0% |
Q2 2018 | $12,821,000 | +67.2% | 2,264,948 | +25.0% | 0.00% | 0.0% |
Q1 2018 | $7,669,000 | -31.7% | 1,812,265 | -13.6% | 0.00% | 0.0% |
Q4 2017 | $11,228,000 | +42.3% | 2,098,693 | +18.7% | 0.00% | 0.0% |
Q3 2017 | $7,888,000 | -16.8% | 1,768,659 | -9.4% | 0.00% | 0.0% |
Q2 2017 | $9,483,000 | -25.1% | 1,951,432 | +11.5% | 0.00% | 0.0% |
Q1 2017 | $12,667,000 | +41.8% | 1,749,732 | +12.0% | 0.00% | 0.0% |
Q4 2016 | $8,935,000 | -51.7% | 1,562,104 | +8.0% | 0.00% | -50.0% |
Q3 2016 | $18,518,000 | +11.4% | 1,446,694 | +8.4% | 0.00% | 0.0% |
Q2 2016 | $16,627,000 | +58.8% | 1,334,295 | +6.6% | 0.00% | +100.0% |
Q1 2016 | $10,468,000 | -10.1% | 1,251,937 | +6.4% | 0.00% | 0.0% |
Q4 2015 | $11,650,000 | -16.0% | 1,176,148 | +4.0% | 0.00% | -50.0% |
Q3 2015 | $13,871,000 | -20.4% | 1,131,054 | -0.5% | 0.00% | 0.0% |
Q2 2015 | $17,431,000 | -7.7% | 1,136,366 | +2.7% | 0.00% | 0.0% |
Q1 2015 | $18,885,000 | +12.5% | 1,106,487 | +0.8% | 0.00% | 0.0% |
Q4 2014 | $16,788,000 | +47.9% | 1,098,011 | +2.5% | 0.00% | +100.0% |
Q3 2014 | $11,350,000 | -31.7% | 1,071,075 | -1.9% | 0.00% | -50.0% |
Q2 2014 | $16,609,000 | +14.4% | 1,092,123 | -3.2% | 0.00% | 0.0% |
Q1 2014 | $14,513,000 | -55.8% | 1,127,754 | -45.2% | 0.00% | 0.0% |
Q4 2013 | $32,800,000 | +92.9% | 2,057,981 | +95.2% | 0.00% | 0.0% |
Q3 2013 | $17,002,000 | +29.9% | 1,054,059 | +6.9% | 0.00% | 0.0% |
Q2 2013 | $13,093,000 | – | 986,208 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|